Mark Fairweather1, Kunal Jajoo2, Nisha Sainani3, Monica M Bertagnolli1, Jiping Wang1. 1. Department of Surgery, Division of Surgical Oncology, Brigham and Women's Hospital, Boston, Massachusetts. 2. Department of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts. 3. Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.
Abstract
BACKGROUND: Neoadjuvant therapy is recommended for locally advanced gastric cancer patients (stage IB-IIIC). The objective of this study is to evaluate the accuracy of endoscopic ultrasound (EUS) and computed tomography (CT) in identifying patients with locally advanced gastric cancer. METHODS: Patients with gastric adenocarcinoma who underwent gastrectomy at our institution were reviewed. Preoperative EUS and CT staging were compared with pathologic staging to determine accuracy. RESULTS: Between 2001 and 2013, 280 patients were identified. Forty-nine patients (18%) who underwent preoperative staging by EUS were analyzed. The accuracy of EUS in identifying individual T stage and N stage was 41.0% and 42.9%, respectively. EUS had moderate accuracy in differentiating locally advanced from early (stage 0-IA) disease (75.5%, area under curve (AUC) 0.772). For individual T stage and N stage, the accuracy of CT was 4.0% and 56%, respectively. CT had relatively poor accuracy in differentiating locally advanced from early disease (60.0%, AUC 0.649). CONCLUSIONS: EUS and CT had poor performance in identifying individual T and N stage although EUS demonstrated moderate accuracy in identifying patients with locally advanced disease. A combined staging approach, in addition to further optimization of staging modalities, is required for accurate staging for patients with gastric cancer.
BACKGROUND: Neoadjuvant therapy is recommended for locally advanced gastric cancerpatients (stage IB-IIIC). The objective of this study is to evaluate the accuracy of endoscopic ultrasound (EUS) and computed tomography (CT) in identifying patients with locally advanced gastric cancer. METHODS:Patients with gastric adenocarcinoma who underwent gastrectomy at our institution were reviewed. Preoperative EUS and CT staging were compared with pathologic staging to determine accuracy. RESULTS: Between 2001 and 2013, 280 patients were identified. Forty-nine patients (18%) who underwent preoperative staging by EUS were analyzed. The accuracy of EUS in identifying individual T stage and N stage was 41.0% and 42.9%, respectively. EUS had moderate accuracy in differentiating locally advanced from early (stage 0-IA) disease (75.5%, area under curve (AUC) 0.772). For individual T stage and N stage, the accuracy of CT was 4.0% and 56%, respectively. CT had relatively poor accuracy in differentiating locally advanced from early disease (60.0%, AUC 0.649). CONCLUSIONS: EUS and CT had poor performance in identifying individual T and N stage although EUS demonstrated moderate accuracy in identifying patients with locally advanced disease. A combined staging approach, in addition to further optimization of staging modalities, is required for accurate staging for patients with gastric cancer.
Authors: Carmen L Mueller; Robert Lisbona; Rafik Sorial; Aya Siblini; Lorenzo E Ferri Journal: J Gastrointest Surg Date: 2019-03-11 Impact factor: 3.452
Authors: Juliana M Costa; Bruno Gonçalves; Maria Miguel Gomes; Dália Fernandes; Raquel Gonçalves; João B Soares Journal: United European Gastroenterol J Date: 2018-12-07 Impact factor: 4.623
Authors: Naruhiko Ikoma; Mariela Blum; Jeannelyn S Estrella; Prajnan Das; Wayne L Hofstetter; Keith F Fournier; Paul Mansfield; Jaffer A Ajani; Brian D Badgwell Journal: Gastric Cancer Date: 2017-06-22 Impact factor: 7.370
Authors: Victor Hugo Fonseca de Jesus; Wilson Luiz da Costa; Tiago Cordeiro Felismino; Vinicius Fernando Calsavara; Alessandro Landskron Diniz; Heber Salvador de Castro Ribeiro; André Luis de Godoy; Igor Correia de Farias; Felipe José Fernandez Coimbra Journal: J Gastrointest Oncol Date: 2019-12